In a compelling demonstration of data-driven investment analysis, InvestingPro's Fair Value model identified a significant ...

MGIC Investment’s price target has just been nudged up to US$30, while the fair value estimate remains at US$28.75. This highlights how small tweaks in the model, rather than a new fair value call, ...

In January 2024, InvestingPro’s Fair Value model identified Vaxcyte, Inc. (NASDAQ:PCVX) as significantly overvalued at $60 per share. This analysis proved remarkably accurate, as the stock has since ...

The premium for the US 10-year Treasury yield continued to fall in August relative to the “fair value” estimate. CapitalSpectator.com’s multi-factor fair-value model has been forecasting for some time ...

When InvestingPro’s Fair Value model flagged Doximity, Inc. (NYSE:DOCS) as significantly overvalued in February 2025, the digital health platform was riding high at $79.23 per share. Fast forward to ...

In the volatile world of quantum computing stocks, timing is everything. Back in October 2025, InvestingPro’s Fair Value models identified Rigetti Computing (NASDAQ:RGTI) as significantly overvalued, ...

Rocket Lab's estimated fair value is US$74.28 based on 2 Stage Free Cash Flow to Equity. Current share price of US$80.48 suggests Rocket Lab is potentially trading c ...